Can low estradiol in men contribute to low HDL cholesterol?

Estradiol is a critical regulator of lipid metabolism in men, operating through specific hepatic pathways to maintain favorable circulating cholesterol profiles.

Hepatic estrogen signaling

• Estrogen Receptor-Alpha (ERα) Regulation: Estradiol actively stimulates hepatic ERα within hepatocytes to modulate key lipid transport genes and suppress de novo lipogenesis. When estradiol levels are low—such as during pharmacological aromatase inhibition—this protective receptor signaling is significantly diminished.
• Apolipoprotein Synthesis: Active ERα signaling is biologically required to upregulate the transcription of apolipoprotein A-I (apoA-I), the essential structural protein backbone necessary for the synthesis and assembly of nascent HDL particles.

Lipoprotein clearance and remodeling

• Hepatic Lipase Suppression: Under physiological estradiol levels, estrogen signaling represses the transcription of the hepatic lipase (LIPC) gene. Deficient estradiol levels relieve this transcriptional inhibition, resulting in elevated hepatic lipase expression and post-heparin activity.
• HDL Catabolism: Elevated hepatic lipase activity accelerates the hydrolysis of triglycerides and phospholipids within circulating HDL particles. This enzymatic remodeling alters HDL particle size and density, driving their rapid clearance from circulation and ultimately lowering serum HDL cholesterol levels.

Bottom line

• Low estradiol in men reduces circulating HDL cholesterol because diminished hepatic ERα signaling simultaneously limits apoA-I synthesis and increases hepatic lipase-mediated HDL clearance.